Key Metrics
CiteScore 

2.5
SJR 

Q2Health Policy

SNIP 

0.74
Recommended pre-submission checks
Powered by 

Topics Covered on ClinicoEconomics and Outcomes Research
ClinicoEconomics and Outcomes Research Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2390 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2009 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in ClinicoEconomics and Outcomes Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in ClinicoEconomics and Outcomes Research
Cost-Effectiveness of Blinatumomab Plus Chemotherapy vs Chemotherapy in Adults Newly Diagnosed with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia in Italy
- 12 Jun 2026
- ClinicoEconomics and Outcomes Research: CEOR
The Cost-Effectiveness and Budget Impact Analysis of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia
- 11 Jun 2026
- ClinicoEconomics and Outcomes Research: CEOR
Real-World Clinical and Economic Outcomes Among Patients with Localized Prostate Cancer Undergoing Radical Prostatectomy Across Different Risk Stratifications in the United States
- 27 May 2026
- ClinicoEconomics and Outcomes Research: CEOR
Cancer Medication Consumptions in Vietnam Between 2019 and 2023: An Analysis from the National Database
- 27 May 2026
- ClinicoEconomics and Outcomes Research: CEOR
Model-Based Cost-Effectiveness Analysis of Routine Omega-3 Testing and Targeted Supplementation to Reduce Early Preterm Birth in Australia Compared with Current Practice
- 26 May 2026
- ClinicoEconomics and Outcomes Research: CEOR
The Socioeconomic Impact of Long-Acting Injectable Buprenorphine
- 20 May 2026
- ClinicoEconomics and Outcomes Research: CEOR
Cost-Effectiveness of Blinatumomab Plus Chemotherapy vs Chemotherapy in Adults Newly Diagnosed with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia in Italy
- 12 Jun 2026
- ClinicoEconomics and Outcomes Research: CEOR
The Cost-Effectiveness and Budget Impact Analysis of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia
- 11 Jun 2026
- ClinicoEconomics and Outcomes Research: CEOR
Real-World Clinical and Economic Outcomes Among Patients with Localized Prostate Cancer Undergoing Radical Prostatectomy Across Different Risk Stratifications in the United States
- 27 May 2026
- ClinicoEconomics and Outcomes Research: CEOR
Cancer Medication Consumptions in Vietnam Between 2019 and 2023: An Analysis from the National Database
- 27 May 2026
- ClinicoEconomics and Outcomes Research: CEOR
Model-Based Cost-Effectiveness Analysis of Routine Omega-3 Testing and Targeted Supplementation to Reduce Early Preterm Birth in Australia Compared with Current Practice
- 26 May 2026
- ClinicoEconomics and Outcomes Research: CEOR
The Socioeconomic Impact of Long-Acting Injectable Buprenorphine
- 20 May 2026
- ClinicoEconomics and Outcomes Research: CEOR